Clinical Trials Directory

Trials / Unknown

UnknownNCT04328675

Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China

Registration Study of Natural History and Clinical Characteristics of Amyotrophic Lateral Sclerosis (ALS) in Mainland China

Status
Unknown
Phase
Study type
Observational
Enrollment
4,752 (estimated)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A multi-center registration study of natural history and clinical characteristics of ALS in mainland China

Detailed description

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease of unknown etiology that is currently incurable. This study is a national multi-center registration study. The study collects general information of ALS patients including medical history, disease characteristics, clinical treatment data, and patient information for different visits in different centers. The aim of the study is: a) describe the distribution of ALS in mainland China(explore the differences in the number of ALS at different times, different regions, and different populations) and further find the reasons that affect the distribution of ALS, b) study the development of ALS in mainland China and the corresponding changes in the characteristics of the disease, c) explore factors that influence the prognosis of ALS.

Conditions

Timeline

Start date
2020-03-20
Primary completion
2023-03-20
Completion
2023-03-20
First posted
2020-03-31
Last updated
2020-04-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04328675. Inclusion in this directory is not an endorsement.